06:30 AM EDT, 05/06/2026 (MT Newswires) -- BeOne Medicines ( ONC ) reported Q1 adjusted earnings Wednesday of $3.24 per diluted American depositary share, up from $1.22 a year earlier.

Three analysts polled by FactSet expected $1.77.

Total revenue for the quarter ended March 31 was $1.51 billion, up from $1.12 billion a year earlier.

Analysts surveyed by FactSet expected $1.44 billion.

BeOne said it now expects 2026 total revenue in the range of $6.3 billion to $6.5 billion, up from its prior range of $6.2 billion to $6.4 billion. Analysts polled by FactSet expect $6.40 billion.